Company: VRCA
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001193125-25-087838
Chunk: 63

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 63
---
193,089 | -3 |
| Equity compensation plans not approved by security holders(4) |     |                  | 2,950,000 |    |     |                   | 0.81 |    |     |                       | 1,550,000 |    |
| Total                                                         |     |                  | 8,389,887 |    |     |                   | 4.72 |    |     |                       | 5,743,089 |    |

| (1) | Consists of shares underlying options and restricted stock units granted pursuant to our 2013 Plan and 2018 Plan. |

| (2) | The weighted-average exercise price includes 384,267 shares included in column a that are issuable upon vesting of restricted stock units which have no exercise price. The weighted average exercise price of the outstanding options was $5.76 per share as of December 31, 2024. |

| (3) | Consists of shares available under the 2018 Plan as of December 31, 2024. On January 1 of each year, the number of shares reserved under the 2018 Plan is automatically increased by 4% of the total number of shares of common stock that are outstanding at that time, or a lesser number of shares as may be determined by our Board of Directors. An additional 3,761,200 shares were added to the number of available shares under the 2018 Plan, effective January 1, 2025. |

| (4) | Represents securities underlying our 2024 Inducement Plan. |

49

TRANSACTIONS WITH RELATED PERSONS Related-Person Transactions Policy and Procedures We have adopted a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. For purposes of our policy only, a related person transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related person is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons. Under the policy, if a transaction has been identified as a related person transaction, including any transaction that